322 related articles for article (PubMed ID: 30452955)
1. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
[TBL] [Abstract][Full Text] [Related]
2. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
[TBL] [Abstract][Full Text] [Related]
4. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
Wilkaniec A; Gąssowska-Dobrowolska M; Strawski M; Adamczyk A; Czapski GA
J Neuroinflammation; 2018 Jan; 15(1):1. PubMed ID: 29301548
[TBL] [Abstract][Full Text] [Related]
6. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
Akhter R; Sanphui P; Das H; Saha P; Biswas SC
J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
[TBL] [Abstract][Full Text] [Related]
7. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
Orellana DI; Quintanilla RA; Maccioni RB
Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
[TBL] [Abstract][Full Text] [Related]
9. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
10. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
12. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
Shi C; Viccaro K; Lee HG; Shah K
J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates Aβ
Zhao L; Zhu L; Guo X
Biomed Pharmacother; 2018 Oct; 106():77-82. PubMed ID: 29957469
[TBL] [Abstract][Full Text] [Related]
14. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.
Nikhil K; Shah K
J Cell Sci; 2017 Sep; 130(18):3023-3039. PubMed ID: 28751497
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
17. Changes in the prefrontal cortex after the hippocampus was injected with Aβ
Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S
Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609
[TBL] [Abstract][Full Text] [Related]
18. Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron.
Chao AC; Chen CH; Wu MH; Hou BY; Yang DI
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118628. PubMed ID: 31884068
[TBL] [Abstract][Full Text] [Related]
19. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
Chang KH; Vincent F; Shah K
J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
Chen J; Li S; Sun W; Li J
PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
